Business Wire

G2 Risk Solutions and EverC Combine to Cement Global Reach and Set a New Standard for AI-Powered Merchant Risk Solutions

5.8.2025 14:30:00 CEST | Business Wire | Press release

Share

Next phase of companies’ collective growth will solidify its position as market leaders in risk management, advancing the resilience of the global digital payments ecosystem

G2 Risk Solutions (G2RS) and EverC today announced the signing of an agreement to combine, representing a significant advancement in the companies’ collective mission to defend global e-commerce from fast-evolving merchant and online marketplace threats. The transaction is expected to close in the third quarter of 2025, subject to customary closing conditions.

Since their founding, the companies have run on parallel tracks, mobilizing advanced technology and deep domain expertise to protect the global digital payments industry’s most influential stakeholders. As one entity, they will set a new standard for innovation, leveraging EverC's advanced AI capabilities to accelerate the most robust product roadmap in the payments risk ecosystem.

Once combined, the two companies will collectively serve nearly every major payment provider on the globe, including leading banks, merchant acquirers, international marketplaces and fast-growing online platforms.

Brian Longe, chief executive officer of G2RS, will serve as CEO of the combined company. EverC CEO Ariel Tiger will serve as an adviser through the end of the year to support a smooth transition. The G2RS and EverC teams will continue to operate globally with offices in the U.S., Europe, India and Israel.

“G2RS and EverC have long traveled toward the same North Star, safeguarding digital commerce and the people who depend on it,” said Longe. “We move forward as one team with a shared vision to redefine what market leadership looks like in the merchant risk space. Leveraging each other’s strengths as a unified force on a singular track, we will accelerate to deliver faster, smarter business outcomes and solutions for our clients and the global digital economy. We’re poised to achieve more together than we ever could apart, aligned in our commitment to root out fraud and illegal activities and help our customers grow with confidence and integrity.”

Tiger echoed Longe’s sentiment, adding “We share a purpose to stop the increasingly sophisticated global threats from bad actors who seek to exploit the payments ecosystem. With our two teams working together, our impact can be exponential. This elevates our game in every facet of the business, pushing the envelope technologically and setting new standards for merchant portfolio performance.”

News of the plan to combine comes on the heels of several major announcements from the market leaders. In Q1 2025, G2RS acquired WebShield owner ZignSec AB, strengthening G2RS’ presence and merchant risk capabilities in Europe. Also this year, EverC rolled out two significant AI-powered product announcements that brought real-time risk intelligence to the payments industry. Those products include an instant merchant onboarding solution that adds merchants faster without introducing increased portfolio risk and a risk assessment solution that automatically scans marketplaces for illicit product listings and regulatory policy violations.

The companies’ mutual impact—exemplified by prominent spots on industry rankings like the RegTech100 and the Top 100 Financial Technology Companies—has grown exponentially in recent years amid the rapid growth of digital commerce and the pressing need to stop fraud, illicit online sales and dangerous transactions.

The mission-focused companies have agreed not to publicly disclose financial terms of the deal.

The transaction is being supported by several advisors, including DLA Piper LLP, which is acting as legal advisor to G2RS; Deutsche Bank, acting as financial advisor to EverC; and Meitar, acting as legal advisor to EverC.

About G2 Risk Solutions

G2 Risk Solutions is the definitive expert in risk and compliance business intelligence for financial institutions and online platforms. We are industry pioneers providing market-leading solutions for merchant risk, digital commerce risk, bankruptcy risk, and credit risk and regulatory reporting. We are driving innovation and shaping the future of risk management through unprecedented data, technology, and global compliance and risk expertise, providing the financial services and digital commerce ecosystems with the tools needed to navigate complex and ever-changing regulatory requirements and mitigate risk. To learn more, visit g2risksolutions.com.

About EverC

EverC is an innovative, mission-driven risk management company using core AI technology to fight bad actors and foster ecommerce growth, empowering a safer digital ecosystem for all. Leveraging a proprietary dataset, EverC solutions identify the patterns that signal risk, generating deep intelligence and holistic insights to map each customer's unique risk universe. EverC helps marketplaces, payment providers, acquirers, and banks mitigate risk while enhancing operational efficiency so they can focus on revenue and scalable growth.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250804313152/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye